FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

426766002: Darifenacin hydrobromide (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2007. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2661566017 Darifenacin hydrobromide (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2675147016 Darifenacin hydrobromide en Synonym Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Darifenacin hydrobromide Is a Darifenacin false Inferred relationship Existential restriction modifier
Darifenacin hydrobromide Has disposition Muscarinic receptor antagonist true Inferred relationship Existential restriction modifier
Darifenacin hydrobromide Is modification of Darifenacin true Inferred relationship Existential restriction modifier
Darifenacin hydrobromide Is a Pyrrolidine true Inferred relationship Existential restriction modifier
Darifenacin hydrobromide Is a Benzofuran true Inferred relationship Existential restriction modifier
Darifenacin hydrobromide Is a Substance with muscarinic receptor antagonist mechanism of action true Inferred relationship Existential restriction modifier
Darifenacin hydrobromide Is a Antispasmodic true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Darifenacin 7.5mg m/r tablet Has active ingredient False Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Darifenacin 15mg m/r tablet Has active ingredient False Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Product containing precisely darifenacin (as darifenacin hydrobromide) 15 milligram/1 each prolonged-release oral tablet Has precise active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier 1
Product containing precisely darifenacin (as darifenacin hydrobromide) 7.5 milligram/1 each prolonged-release oral tablet Has precise active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier 1
Emselex 15mg modified-release tablets (Ethigen Ltd) Has specific active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Ethigen Ltd) Has specific active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Emselex 15mg modified-release tablets (Ethigen Ltd) 28 tablet Has specific active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Ethigen Ltd) 28 tablet Has specific active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has specific active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Emselex 15mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has specific active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Emselex 15mg modified-release tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (CST Pharma Ltd) 28 tablet Has specific active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (CST Pharma Ltd) Has specific active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Emselex 15mg modified-release tablets (CST Pharma Ltd) 28 tablet Has specific active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Emselex 15mg modified-release tablets (CST Pharma Ltd) Has specific active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Darifenacin 7.5mg modified-release tablets Has specific active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Darifenacin 15mg modified-release tablets Has specific active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (DE Pharmaceuticals) 28 tablet Has specific active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (DE Pharmaceuticals) Has specific active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Emselex 15mg modified-release tablets (DE Pharmaceuticals) Has specific active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Emselex 15mg modified-release tablets (DE Pharmaceuticals) 28 tablet Has specific active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Darifenacin 7.5mg modified-release tablets 28 tablet Has specific active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Darifenacin 7.5mg m/r tablet Has specific active ingredient False Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) Has specific active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Darifenacin 15mg m/r tablet Has specific active ingredient False Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Emselex 15mg modified-release tablets (Aspire Pharma Ltd) Has specific active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Darifenacin 15mg modified-release tablets 28 tablet Has specific active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Emselex 15mg modified-release tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) Has active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Emselex 15mg modified-release tablets (Aspire Pharma Ltd) Has active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Darifenacin 15mg modified-release tablets (J M McGill Ltd) Has specific active ingredient False Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Darifenacin 15mg modified-release tablets (J M McGill Ltd) 28 tablet Has specific active ingredient False Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Darifenacin 7.5mg modified-release tablets Has specific active ingredient False Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Darifenacin 15mg modified-release tablets Has specific active ingredient False Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Originalis B.V.) Has specific active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Emselex 15mg modified-release tablets (Originalis B.V.) Has specific active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Originalis B.V.) 28 tablet Has specific active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier
Emselex 15mg modified-release tablets (Originalis B.V.) 28 tablet Has specific active ingredient True Darifenacin hydrobromide Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start